LMRI · Nasdaq · CIK 0002071288
Lumexa Imaging Holdings, Inc.
Lumexa Imaging Holdings, Inc.’s most recent SEC filing in our snapshot is a Form SCHEDULE 13G filed on Aug 14, 2026. Its EDGAR record lists 17 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- Lumexa Imaging Holdings, Inc.
- Ticker
- LMRI
- SEC Central Index Key (CIK)
- 0002071288
- Industry (SIC)
- Services-Medical Laboratories (code 8071)
- Business address
- RALEIGH, NC
- State or country of incorporation
- DE
- Fiscal year ends
- December 31
- SEC filer category
- Non-accelerated filer<br>Emerging growth company
- Position in SEC ticker list
- #2404 of the 3,000 companies we track
Five-year financial highlights
We could not find standardized annual figures for Lumexa Imaging Holdings, Inc. in the SEC’s XBRL company facts. Read the latest annual report directly on EDGAR.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
| Filed | Form | What it is | Original |
|---|---|---|---|
| Mar 30, 2026 | 10-K | Annual report· period Dec 31, 2025 | Document · Index |
| Aug 13, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Aug 12, 2026 | 8-K | Results of operations; Regulation FD disclosure· period Aug 12, 2026 | Document · Index |
| Apr 28, 2026 | DEF 14A | Definitive proxy statement· period Jun 10, 2026 | Document · Index |
Recent SEC filings
The 40 newest documents filed by or about Lumexa Imaging Holdings, Inc., by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G | Passive beneficial ownership report (over 5%) | Document · Index |
| Aug 13, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Aug 12, 2026 | 8-K | Results of operations; Regulation FD disclosure· period Aug 12, 2026 | Document · Index |
| Jun 30, 2026 | 8-K | Material agreement; New financial obligation· period Jun 30, 2026 | Document · Index |
| Jun 12, 2026 | 8-K | Shareholder vote results· period Jun 10, 2026 | Document · Index |
| Jun 12, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 10, 2026 | Document · Index |
| Jun 12, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 10, 2026 | Document · Index |
| Jun 12, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 10, 2026 | Document · Index |
| Jun 12, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 10, 2026 | Document · Index |
| Jun 12, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 10, 2026 | Document · Index |
| Jun 12, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 10, 2026 | Document · Index |
| Jun 12, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 10, 2026 | Document · Index |
| May 21, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 19, 2026 | Document · Index |
| May 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 14, 2026 | Document · Index |
| May 12, 2026 | 10-Q | Quarterly report· period Mar 31, 2026 | Document · Index |
| May 12, 2026 | 8-K | Results of operations; Regulation FD disclosure· period May 12, 2026 | Document · Index |
| Apr 28, 2026 | ARS | ARS· period Dec 31, 2025 | Document · Index |
| Apr 28, 2026 | DEFA14A | Additional proxy soliciting materials | Document · Index |
| Apr 28, 2026 | DEF 14A | Definitive proxy statement· period Jun 10, 2026 | Document · Index |
| Apr 9, 2026 | 8-K | Regulation FD disclosure· period Apr 8, 2026 | Document · Index |
| Mar 30, 2026 | 10-K | Annual report· period Dec 31, 2025 | Document · Index |
| Mar 26, 2026 | 8-K | Results of operations; Regulation FD disclosure· period Mar 26, 2026 | Document · Index |
| Mar 2, 2026 | 8-K | Results of operations; Regulation FD disclosure· period Mar 2, 2026 | Document · Index |
| Feb 27, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Feb 25, 2026 | Document · Index |
| Feb 13, 2026 | SCHEDULE 13G | Passive beneficial ownership report (over 5%) | Document · Index |
| Jan 15, 2026 | 8-K | Director or officer change· period Jan 12, 2026 | Document · Index |
| Jan 15, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Dec 12, 2025 | Document · Index |
| Jan 15, 2026 | 3 | Initial statement of beneficial ownership· period Dec 11, 2025 | Document · Index |
| Dec 30, 2025 | 4 | Statement of changes in beneficial ownership (insider trade)· period Dec 12, 2025 | Document · Index |
| Dec 30, 2025 | 3 | Initial statement of beneficial ownership· period Dec 11, 2025 | Document · Index |
| Dec 18, 2025 | 8-K | Material agreement; New financial obligation· period Dec 17, 2025 | Document · Index |
| Dec 18, 2025 | 3 | Initial statement of beneficial ownership· period Dec 11, 2025 | Document · Index |
| Dec 16, 2025 | 4 | Statement of changes in beneficial ownership (insider trade)· period Dec 12, 2025 | Document · Index |
| Dec 16, 2025 | 4 | Statement of changes in beneficial ownership (insider trade)· period Dec 12, 2025 | Document · Index |
| Dec 16, 2025 | 4 | Statement of changes in beneficial ownership (insider trade)· period Dec 12, 2025 | Document · Index |
| Dec 16, 2025 | 4 | Statement of changes in beneficial ownership (insider trade)· period Dec 12, 2025 | Document · Index |
| Dec 16, 2025 | 4 | Statement of changes in beneficial ownership (insider trade)· period Dec 12, 2025 | Document · Index |
| Dec 15, 2025 | 3 | Initial statement of beneficial ownership· period Dec 11, 2025 | Document · Index |
| Dec 15, 2025 | 3 | Initial statement of beneficial ownership· period Dec 11, 2025 | Document · Index |
| Dec 12, 2025 | 8-K | Material agreement; Director or officer change; Charter, bylaws or fiscal year change; Other events· period Dec 12, 2025 | Document · Index |
Insider filing activity
17 Form 4 filings appear in Lumexa Imaging Holdings, Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Services-Medical Laboratories
- NTRA Natera, Inc.
- LH LABCORP HOLDINGS INC.
- DGX QUEST DIAGNOSTICS INC
- GH Guardant Health, Inc.
- CAI Caris Life Sciences, Inc.
- GRAL GRAIL, Inc.
- RDNT RadNet, Inc.
- BLLN BillionToOne, Inc.
All 17 companies in Services-Medical Laboratories· Companies headquartered in North Carolina
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0002071288 and XBRL company facts. Lumexa Imaging Holdings, Inc. on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement